Betty Gardie

3.1k citations
36 papers · 1.3k indexed · h-index 15

Betty Gardie

34 papers receiving 1.3k citations

Peers

Betty Gardie
Comparison fields: 5 of 80
  • Cancer Research 516
  • Genetics 172
  • Hematology 139
  • Molecular Biology 803
  • Endocrinology, Diabetes and Metabolism 121
Replace Irene A. Rigault de la Longrais with:
Irene A. Rigault de la Longrais Italy
Outi Vierimaa Finland
Dean Gentle United Kingdom
Xianguo Kong United States
Lynette J. Schedlich Australia
Veronica A. Carroll United Kingdom
Karoline Kollmann Austria
Colleen Wu United States
Rachel Bikoff United States
Kaname Yamashita Japan
Betty Gardie relative to Irene A. Rigault de la Longrais Italy Irene A. Rigault de la Longrais's profile →
Citations per field
00.5×3.9×
Irene A. Rigault de la Longrais · 1×
Citations per year

Countries citing papers authored by Betty Gardie

Since Specialization
Citations

This map shows the geographic impact of Betty Gardie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Gardie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Gardie more than expected).

Fields of papers citing papers by Betty Gardie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty Gardie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Gardie. The network helps show where Betty Gardie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Betty Gardie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Betty Gardie Line = papers co-authored together Betty Gardie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20232
3 20232
4 20220
5 20228
6 20217
7 20217
8 20201
9 20183
10 201793
11 201727
12 201576
13 201437
14 201358
15 201273
16 201138
17 2011314
18 2008242
19 200822
20 200271

About Betty Gardie

Betty Gardie is a scholar working on Genetics, Cancer Research and Aging, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Erythrocyte Function and Pathophysiology (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Hemoglobinopathies and Related Disorders (6 papers), Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (5 papers), Kruppel-like factors research (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Cancer Research (516 citations), Genetics (172 citations) and Hematology (139 citations). Betty Gardie has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Richard J. Kahnoski, Sophie Gad, François Sigaux, Jean‐Michel Cayuela, M Leporrier, Romain Carcenac, Jean Feunteun, Jacques Pouysségur, Edith Bigot‐Corbel and Sylvie Hermouet. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026